chrisvoncsefalvay/vaers-outcomes huggingface dataset:
First vaccine on April 5th, 24  hours later I had painful blisters in my chest Second vaccine on April 26.  Had no immediate symptoms but on May 13 I started having pain in my gums, then severe canker sores all over my mouth. Could not eat, sleep or talk.  I thought it was mouth infections and went to see my dentist but I was told they were canker sores.  He thought it was unusual to have that many especially when I had not diet change,  eat home cooked meals, with normal stress level.  He asked about the vaccine.  Later I googled on the internet and found out other Pfizer patients had same reaction.
Initial unsolicited report received from a nurse on 30 JUNE 2015. A 55-year-old female patient had received an intramuscular second dose of INFLUENZA (batch number U5101FA, expiry date 30 JUNE 2015) in left deltoid on 29 JUNE 2014 at (21:00 hours). The patient's illness at the time of vaccination, pre-existing physician-diagnosed allergies, birth defects medical condition, concomitant medications and past drug history was none. The patient was vaccinated at clinic and vaccine was purchased with private funds. The patient had previously received 1 dose of INFLUENZA on an unspecified date in past and adverse event following prior vaccination was reported as "denus" (not legible). On 29 JUNE 2015, at (22:30 hours) i.e. 1.5 hour after the vaccination the patient was not feeling well, felt weak and tired. By the midnight the patient developed fever and body hurt (date not specified). Laboratory investigations were reported as none and corrective treatments were not reported. At the time of this report the patient outcome was unknown. Documents held by sender: none. Follow up information received from a nurse on 23 JULY 2015. On 03 JULY 2015, the patient recovered from the above mentioned events. Documents held by sender: none. Follow up information received from a nurse on 11 AUGUST 2015. No new information reported.
Initial information received on 07-Jun-2018 regarding an unsolicited valid non-serious case received from a physician. This case involves Adult patient who experienced dose given to a pt on 03-Jun-2015 and on 22-Jun-2015. Too close together, while he/she received vaccine PENTACEL. The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided. On 03-Jun-2015, the patient received a dose Primary dose of suspect DIPHTHERIA/TETANUS/5 HYBRID AC PERTUSSIS/IPV(MRC5)/HIB(PRP/T) VACCINE lot number not reported via unknown route in unknown administration site. On 22-Jun-2015 he/she also received a dose Primary dose of the same vaccine with an unknown batch number via unknown route in unknown administration site. It was a case of actual medication error because actual administration of vaccine at inappropriate schedule took place. (Other relevant tests included no lab data.) Final diagnosis was dose given to a pt on 03-Jun-2015 and on 22-Jun-2015. Too close together. It was not reported if the patient received a corrective treatment. The patient outcome is reported as Not Applicable for dose given to a pt on 03-Jun-2015 and on 22-Jun-2015. Too close together. This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error. Documents held by sender: none.
This spontaneous report as received from a Licensed Practical Nurse referring to multiple unspecified patients of unknown age and gender. The patients' pertinent medical history and concurrent conditions were not reported. On unknown dates, the patients were vaccinated with improperly stored dose of GARDASIL 9 lot # L020015 with expiration date of 16-OCT-2017 and lot # L048459 with expiration date of 22-FEB-2018 (anatomical route of vaccination and dose number were not provided). The patients' concomitant medications were not reported. It was also reported by the Licensed Practical Nurse, that GARDASIL 9 lot # L020015 with expiration date of 16-OCT-2017 was exposed to a temperature excursion of 23.4 degree C for 3842 minutes and lot # L048459 with expiration date of 22-FEB-2018 was exposed to 23.4 degree C for 968 minutes. No previous excursion was stated. Furthermore, no adverse event was reported and no product quality issue was involved. This is one of several reports received from the same reporter. Additional information has been requested.
A couple of hours after the vaccination, I felt really shaky and felt like I was going to pass out. Everything was fine within 15 minutes of 1st feeling shaky. I did not go to the doctor. I feel like I have not been 100% myself after the 1st vaccine.
Mother presented to clinic with patient for 2nd flu vaccine this season. RN explained purpose of vaccine, mode of admin, and potential side effects. VIS given and explained as well. Verified no previous allergies to vaccine or its components. Mother verbalized understanding. RN administered 0.5 dose ml of FLUZONE. Pt tolerated injection well. RN realized that 0.5 ml FLUZONE dose was incorrect amount. No adverse reaction noted. RN notified nurse manager and provider. RN also notified parents.
Information has been received from a nurse concerning a 26 year old female patient with asthma who on 22-SEP-2009 was vaccinated IM with 0.5 ml PNEUMOVAX 23 (Lot# 663486/0507Y). Subsequently the patient developed a severe local reaction. The patient experienced pain at the site and could barely move her arm. She had a pink speckled rash on both arms, neck and chest. Before receiving PNEUMOVAX 23 she had a mild virus. After the PNEUMOVAX 23 she was achy and short of breath, but they were not sure if those symptoms were related to the virus or vaccination. It was believed to be the first PNEUMOVAX 23 vaccine for this patient. It was the same lot as the other cases previously reported. A lot check was being done on 0507Y. The patient was taken to a local emergency room. Hospital name was not available. It was unknown if the patient was admitted or present status of the patient. Upon internal review, short of breath was determined to be an other important medical event. This is one of several reports for the same source. Additional information has been requested.
Patient received first dose of COVID vaccine. Approximately 10 minutes later patient was experiencing palpitations, dizziness and lightheadedness. Brought patient to exam room to be seen by onsite provider, BP: 130/70 Pulse: 122-140  Oxygen saturation 98%  No rash, no hives. Reports no SOB however increased work of breathing.  Patient felt increasingly dizzy and felt shaky. Patient had near syncopal episode.  EMS was called and patient taken to ER.
Miscarriage. Had first vaccine dose about 2 weeks after a positive home pregnancy test (on 04/24/2021). Date of last period was 03/19/2021. No fertility treatments. Spontaneous pregnancy at 46 years old. Had 2 previous miscarriages - 6 months earlier and 3 years earlier. Started bleeding and cramping 05/26/2021. Went to emergency room. They checked with ultrasound and said it was probably a miscarriage. The baby should be 9 or 10 weeks, but the ultrasound showed it was much too small for that - probably stopped developing at about 6 weeks. Pregnancy hormone levels were normal, however. Followed up with OBGYN the next day - she confirmed it looked like a miscarriage. The cramping/bleeding lasted for another week. Follow-up appointment on 06/04/2021 showed the uterus had completely emptied.
presumably anaphylaxis.; baby broke out in hives; course cough; wheezing; she breastfed her 12 month-old infant shortly thereafter without problem. around 1215 baby was getting fussy and breastfed for ab; she breastfed her 12 month-old infant shortly thereafter without problem. around 1215 baby was getting fussy and breastfed for ab; This is a spontaneous report from a contactable pharmacist. This pharmacist reported information for both mother and baby. This is a baby report.   A 12-month-old patient of an unspecified gender received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) dose 1 via transmammary on 20Mar2021 as a single dose for Covid-19 immunization.The medical history and concomitant medication not reported.The patient mother received first in series covid vaccine on 20Mar2021 09:15 and she breastfed her 12-month-old infant shortly thereafter without problem. On 20Mar2021, around 12:15, patient was getting fussy and breastfed for about 5 minutes before baby broke out in hives. EMS was called and epinephrine/diphenhydramine (Benadryl) administered for course cough/wheezing, presumably anaphylaxis. Other foods consumed by patient on same day included banana, kids fig newton bar, dried apples, meat from frozen meal, and two piece of 'Trix' cereal (new to baby). ER course required 4 hours of monitoring. The events result in emergency room/department or urgent care. The outcome of the events was recovered in Mar2021.; Sender's Comments: Based on the temporal association, there is a reasonable possibility that the administration of vaccine with BNT162B2 in the mother played a contributory role in triggering the onset of the events in the infant exposed to the suspect product via breast milk. ,Linked Report(s) : US-PFIZER INC-2021305721 mom/baby
First injection 2/13/2021, second 3/13/21. Extreme vertigo on May 14, 2021. Required hospitalization.
tinnitus and possibly caused eye floater almost immediately after second dose. Has lasted consistently for almost a year now.
On October 6, 2021, I developed severe arrhythmia and needed to be hospitalized for two nights. I later had to visit the ER again due to severe arrhythmia on 10/15/21 but did not require hospitalization. I later developed severe arrhythmia on 10/27/21 and was hospitalized for three nights. I will be requiring cardiac ablation scheduled for 11/11/21.
This case was reported by a pharmacist and described the occurrence of injection site redness in a male subject of unspecified age who was vaccinated with FLULAVAL (GlaxoSmithKline). Concurrent medical conditions included diabetes. Concurrent medications included insulin. On 19 December 2010 the subject received a dose of FLULAVAL (.8 ml, subcutaneous, unknown) accidentally through his insulin pump and experienced inappropriate route of vaccination and unintentional  overdose. On 19 December 2010, less than one week after vaccination with FLULAVAL, the subject experienced injection site redness. At the time of reporting the outcome of the unintentional overdose and injection site redness were unspecified.
Patient with a vesicular pustular rash on face. Spreading to the trunk and then extremities. Associated with fever. Discharge summary states puritis. msv
HERING VOICES seems to have a spritualistic meaning/ psyche or possible to explain by biohacking ? appointed at the hospital with psychosis seeing lights, followed by blood check ups - good results
Pain associated with index finger on left hand following 2nd dose.  Pain primarily in the joint at the base of the finger.  Pain occurs when either using the muscles in that finger or from any contact made to the joint at the base of the finger.
Burning sensation; Cannot sleep at night; Fever; Vomiting; Chills; Sickness; Cold; Feeling hot; Pain in arm; I cant hardly lift it, when i pick up something / i can't hardly raise that arm; Blister; Lip pain; Face so red; This spontaneous case was reported by a patient and describes the occurrence of ILLNESS (Sickness), NASOPHARYNGITIS (Cold), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Pain in arm) and MOBILITY DECREASED (I cant hardly lift it, when i pick up something / i can't hardly raise that arm) in a female patient of an unknown age who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 010H22A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 26-Oct-2022, the patient received fifth dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. On 27-Oct-2022, the patient experienced ILLNESS (Sickness), NASOPHARYNGITIS (Cold), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Pain in arm), MOBILITY DECREASED (I cant hardly lift it, when i pick up something / i can't hardly raise that arm), BLISTER (Blister ), LIP PAIN (Lip pain), ERYTHEMA (Face so red) and CHILLS (Chills). On an unknown date, the patient experienced BURNING SENSATION (Burning sensation), INSOMNIA (Cannot sleep at night), PYREXIA (Fever) and VOMITING (Vomiting). At the time of the report, ILLNESS (Sickness) had not resolved and NASOPHARYNGITIS (Cold), FEELING HOT (Feeling hot), PAIN IN EXTREMITY (Pain in arm), MOBILITY DECREASED (I cant hardly lift it, when i pick up something / i can't hardly raise that arm), BLISTER (Blister ), LIP PAIN (Lip pain), ERYTHEMA (Face so red), BURNING SENSATION (Burning sensation), INSOMNIA (Cannot sleep at night), PYREXIA (Fever), VOMITING (Vomiting) and CHILLS (Chills) outcome was unknown.            No concomitant product reported by reporter.  Patient felt so bad, lips were hurting so bad like they have fluid in them. COVID-19 shot broke patient out all over the face, neck, back and legs. Running a fever. Patient could not keep water down or anything. It was reported that patient received Dose 1 on 01-Mar-2020 with lot 006M20A, Dose 2 on  29-Mar-2020 with lot 064A21A , Dose 3 on 06-Jan-2022 , Dose 4 on 29-Apr-2022 from moderna.  No treatment medication reported by reporter.   This case was linked to MOD-2023-712194 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 22-Feb-2023: Significant live follow-up received. Events added. Patient details added.
Pt.'s mom stated he was due for his booster, according to database at the time, he had two previous doses on 5/18/21 and 6/8/21 (not given within our clinic). After he left, mom called to let us know she was mistaken and he already received a booster dose on 3/8/22 (not given within our clinic). When going in to database to check this, there was a reconcilable vaccine and it was the 3/8/22 booster dose. He received a second booster or 4th dose.
For the first time in my life, I had blood in my stool. At 10 pm on the same day of my injection.  03/09/2021.
I have had a distorted sense of smell and of taste. I cannot pinpoint the exact date of onset, because I did not realize , that my sense was altered. This has been going on since  the end of May, and is still an issue. Weird smells, smells that don?t match up with what they are( like coffee and chocolate smell the same, but not how I remember them smelling  for example ), phantom smells, like smoke when there isn?t.  Laundry detergent  smells are not there and underlying odors remain. I explain it as, my body knows there is a smell, like there is a trigger. But it doesn?t match up with what it has smelled like in the 46 years prior . Coca Cola taste like fresh green peppers yet when I eat green peppers they have no taste .
This case was reported by a consumer via call center representative and described the occurrence of erythematous rash in a 92-year-old female patient who received SHINGRIX (batch number 7FY22, expiry date 25th April 2020) for prophylaxis. Co-suspect products included (non-proprietary) Cortisone Shot for an unknown indication. Previously administered products included ZOSTAVAX (received in 2007). On 9th May 2018, the patient received the 1st dose of SHINGRIX (intramuscular) 50 mcg/mg. On an unknown date, the patient started Cortisone Shot at an unknown dose and frequency. In July 2018, between 1 and 3 months after receiving SHINGRIX, the patient experienced erythematous rash. On an unknown date, the patient experienced scab and dry skin. The action taken with Cortisone Shot was unknown (Dechallenge was unknown). Rechallenge with Cortisone Shot was unknown. On an unknown date, the outcome of the erythematous rash and scab were recovering/resolving and the outcome of the dry skin was unknown. It was unknown if the reporter considered the erythematous rash, scab and dry skin to be related to SHINGRIX. Additional details were provided as follows: The caller stated that the patient received SHINGRIX on left arm. Two months ago from the reporting date, the patient experienced rash of red little bumps on the left side of her neck. The caller stated that less than 5 months after receiving SHINGRIX, they were improved in that they were scabs and more dry. The reporter noted that she also had a few under her left breast. The caller also stated that she had a Cortisone shot in her left knee, but cannot recall the timing of that and the rash appearance. The patient stated that the rash never hurt, but wondered if it could be shingles. The caller was referred to her physician for diagnosis and awareness. The caller will receive authorization letter to provide healthcare professional information at a later time. It was unknown if the reporter considered the rash, scab, erythematous rash and shingles to be related to Cortisone shot as well.
Fever, Vomiting, Diarrhea, Headache, Body aches.
Pulmonary embolisms. Shortness of breath starting about 36 hours after injection.   Treated with oxygen, Eliquis  and Metropolol
Syncope approx 10-15 seconds after TDAP and GARDASIL #1. Response after 10 sec. Discharged after 1/2 hour in good condition.
High pitched crying began 3 hrs post vax cont x 30 mins; calm x 20 mins then resumed crying x 30-45 mins; refused to drink no wet diaper x 6 hrs; high pitched crying cont all afternoon; fussy;
Fever and fussines developed after receiving vaccines Tmax of 101, higher than expected for normal immune response to vaccines No s/s of infection or other illness Continue ibuprofen, may add APAP as needed when ibuprofen wears off prior to 6 hours Push fluids to prevent dehydration F/u tomorrow if not significantly improved
Low-grade fever, fatigue enough to stay in bed all day, general muscle aches, left arm very sore, red and hot to the touch.   No treatment.  Took fluids, rested and was groggy the next day, but able to work. Third day, I felt normal.
Information has been received from a lawyer regarding a case in litigation concerning a female patient of unknown age. No information was received regarding the patient's past medical history, concurrent conditions, or concomitant medication. The patient's healthcare provider recommended, and/or prescribed ZOSTAVAX to the patient for its intended purpose of permanent prevention and protection against shingles and zoster-related conditions. On or about 16-NOV-2012, a health care provider administered the ZOSTAVAX to the patient (lot number, dosage and route of administration not provided). On or about 13-JUN-2013, the patient was treated by a healthcare provider for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX vaccine, and suffered serious physical, emotional, and economic damages as a result of the patient's injuries. As a direct and proximate result of the ZOSTAVAX vaccine, the patient has and will continue to suffer ongoing injuries, including but not limited to: mental and physical pain and suffering; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs including care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death; aggravation of preexisting conditions and activation of latent conditions (unspecified); lost wages; loss of earnings capacity; and other losses and damages. The outcome of the events was considered to be not recovered.  Additional information has been requested.
Heartbeats irregular; bradycardia; the monitor said I have premature atrial contraction; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of BRADYCARDIA (bradycardia), SUPRAVENTRICULAR EXTRASYSTOLES (the monitor said I have premature atrial contraction) and HEART RATE IRREGULAR (Heartbeats irregular) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A.) for COVID-19 vaccination.     The patient's past medical history included Cancer on 01-May-2019. Concomitant products included XYLITOL (XYLIMELTS) for Dry mouth, TAMSULOSIN and FINASTERIDE for Enlarged prostate.   On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 05-May-2021, the patient experienced BRADYCARDIA (bradycardia) and SUPRAVENTRICULAR EXTRASYSTOLES (the monitor said I have premature atrial contraction). On 16-Jun-2021, the patient experienced HEART RATE IRREGULAR (Heartbeats irregular). On 05-May-2021, BRADYCARDIA (bradycardia) and SUPRAVENTRICULAR EXTRASYSTOLES (the monitor said I have premature atrial contraction) had resolved. At the time of the report, HEART RATE IRREGULAR (Heartbeats irregular) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 05-May-2021, Electrocardiogram: abnormal (abnormal) premature atrial contraction. On 05-May-2021, Heart rate: low (Low) bradycardia was diagnosed more than 1 time and 36 (Low) The patient normal pulse rate is in the low 50s. On 27-May-2021, Heart rate: 47-48 (Inconclusive) 47-48,which is closer to his normal pulse rate.         Patient has historical condition of cancer which was treated with HCP radiation. Patient is using high fluoride toothpaste to not have infection in mouth due to patient's throat cancer. patient went in on 05MAY2021 for a 2-year follow-up of his throat cancer and was told that he was in remission. patient was admitted to ER had no other symptoms, so  was released from the Emergency Room.Patient had an appointment with cardiologist physiologist on 07MAY2021.The patient was asymptomatic so not treated with  any medication treatment for the event of low pulse rate.  Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.   This case was linked to MOD-2021-187134.   Most recent FOLLOW-UP information incorporated above includes: On 16-Jun-2021: Follow-up added on 16-Jun-2021 included significant data: New event added. Reporter details updated.; Sender's Comments: Based on current available information and the temporal association between product use and the start date of the events a causal relationship cannot be excluded.
This spontaneous report as received from a registered nurse refers to a 4 year-old patient of unknown gender. The patient's concurrent conditions and medical history were not reported. Concomitant therapies included sterile diluent (MERCK). On 10-MAY-2018, the patient was vaccinated with an inappropriate storage dose of PROQUAD (strength, dose and route of administration were unknown) with lot # N023965 and expiration date of 28-FEB-2019 for prophylaxis, which was stored at a temperature ranges from 15°F to 46°F for 62 hours. There was a digital data logger involved. Previous temperature excursion was from 15°F to 46°F for 78 hours and 51 minutes. No adverse effects were reported. This is one of several reports received from the same reporter. Sender's Comments: US-009507513-1805USA007992: US-009507513-1805USA007365.